Hypertension care cascade under dual guideline criteria was analyzed in 238,738 adults from Peru

This repeated cross-sectional analysis evaluated the hypertension care cascade using dual guideline criteria from 2023 ESH and 2025 ACC/AHA. The study population consisted of 238,738 adults aged 18 years or older from Peru. The analysis was conducted in the Peru setting and did not report a specific comparator group. No primary outcomes, secondary outcomes, or follow-up duration were reported in the source document. Safety data including adverse events, serious adverse events, discontinuations, and tolerability were not reported. Funding sources and conflicts of interest were not reported. The authors did not provide specific practice relevance or certainty notes regarding the findings. Limitations of the study were not explicitly detailed in the provided information. Because the study is observational and lacks reported outcomes, causal interpretations cannot be made. Clinicians should interpret these data with caution given the missing outcome measures and lack of reported safety signals.